With relatively small populations (Australia 26 million and Israel almost 10 million), both countries “punch well above their weight” when it comes to clinical research.
Australia and Israel also have a long and well-developed networks of scientific collaborations and, as two robust democracies, shared values.
Over the past forty years, a well-honed ecosystem of scientific excellence and innovation has also seen Israel become a leader in medical investigation. There is virtually no area of medical research to which Israel has not made significant contributions - cardiology, genetics, neurology and ophthalmology being just some of the areas which have benefited. In an era where one of the biggest opportunities for discovery in medical research lies in the convergence between technology and biology, Israel has a globally acknowledged competitive edge.
In Australia more than 32,000 medical researchers carry out their world-leading research in local institutes, hospitals and universities and this has led to life-changing discoveries including the artificial heart valve (Victor Chang), in vitro fertilisation (Carl Wood), understanding a major risk factor for sudden infant death syndrome (SIDS) (Terry Dwyer), understanding the role of antibodies in the immune system (Gustav Nossal), and the discovery that the bacteria, Helicobacter pylori, leads to gastritis and peptic ulcers (Barry Marshall & Robin Warren).